News | January 03, 2026
Cupid reports record Q3, eyes GCC expansion with Saudi FMCG facility
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
Once finalized, cough syrups will no longer be available for over-the-counter sale
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The Co-Dx PCR platform is designed to deliver gold-standard PCR accuracy in a compact, user-friendly device suitable for decentralized testing environments
The applications aim to launch Phase Ib/II trials for relapsed/refractory multiple myeloma and primary plasma cell leukemia, respectively
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
CuraTeQ Biologics and BioFactura USA to terminate agreement mutually
Tolebrutinib had been provisionally approved in the United Arab Emirates in July 2025 for nrSPMS to slow disability accumulation independent of relapse activity
The drug had previously received orphan drug designation for this rare cancer on March 31, 2025
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
Subscribe To Our Newsletter & Stay Updated
